Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total of 36 start ups from Colorado’s designated Advanced Industries will receive $8.6 million in funding. 

The Advanced Industries Accelerator Grant Program is a critical source of non-dilutive funding for Colorado life sciences companies and organizations. It demonstrates a significant return on investment, delivering value back to the state through company creation and high-paying jobs.

Since inception, the program’s success metrics for life sciences alone include:

CBSA members receiving grants from the current cycle are:

---

Congratulations to all grant recipients from Colorado’s innovation economy including several from our life sciences ecosystem:

Boulder Sterilization, Boulder, $250,000 Ceria Therapeutics, Aurora, $250,000 EZaLife, Boulder, $250,000 HiveTech Solutions, Westminster, $500,000 Link to Learn, Denver, $247,195 New West Genetics, Fort Collins, $250,000 Op-T, Denver, $250,000 Orbit Genomics, Boulder, $250,000 Phase IV Engineering, Boulder, $381,000 Rock Immune, Denver, $250,000 Serenity App, Denver, $100,000 Vona Oncology, Westminster, $250,000

Read about the success achieved by past winners of these state-funded grants in the 2020-2021 Bioscience Colorado magazine.

Our Policy + Advocacy team works closely with OEDIT to highlight the importance of the Advanced Industries Accelerator Grant Program to our life sciences community. We advocate for full program funding and applaud the state legislature for providing a one-time, $10 million infusion for the program earlier this year after budget cuts in 2020. 

CBSA applauds the success of the Advanced Industries Accelerator Grant recipients and is proud to support this vital program.